Search Results - "Ooi, Makoto"

Refine Results
  1. 1
  2. 2
  3. 3

    Clinical outcomes of deep invasive submucosal colorectal cancer after ESD by Watanabe, Daisuke, Toyonaga, Takashi, Ooi, Makoto, Yoshizaki, Tetsuya, Ohara, Yoshiko, Tanaka, Shinwa, Kawara, Fumiaki, Ishida, Tsukasa, Morita, Yoshinori, Umegaki, Eiji, Matsuda, Takeru, Sumi, Yasuo, Nishio, Mari, Yokozaki, Hiroshi, Azuma, Takeshi

    Published in Surgical endoscopy (01-04-2018)
    “…Background and study aims Endoscopic submucosal dissection (ESD) is a reliable method that can replace surgery under certain conditions. However, limited…”
    Get full text
    Journal Article
  4. 4

    A Role of the Aryl Hydrocarbon Receptor in Attenuation of Colitis by Furumatsu, Keisuke, Nishiumi, Shin, Kawano, Yuki, Ooi, Makoto, Yoshie, Tomoo, Shiomi, Yuuki, Kutsumi, Hiromu, Ashida, Hitoshi, Fujii-Kuriyama, Yoshiaki, Azuma, Takeshi, Yoshida, Masaru

    Published in Digestive diseases and sciences (01-09-2011)
    “…Background and Aims The aryl hydrocarbon receptor (AhR), which is a member of the basic helix-loop-helix/Per-Arnt-Sim homology superfamily, plays an important…”
    Get full text
    Journal Article
  5. 5

    GC/MS-based profiling of amino acids and TCA cycle-related molecules in ulcerative colitis by Ooi, Makoto, Nishiumi, Shin, Yoshie, Tomoo, Shiomi, Yuuki, Kohashi, Michitaka, Fukunaga, Ken, Nakamura, Shiro, Matsumoto, Takayuki, Hatano, Naoya, Shinohara, Masakazu, Irino, Yasuhiro, Takenawa, Tadaomi, Azuma, Takeshi, Yoshida, Masaru

    Published in Inflammation research (01-09-2011)
    “…Objective The roles that amino acids play in immunity and inflammation are well defined, and the relationship between inflammatory bowel disease (IBD) and…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Efficacy and predictor of anti-TNFα agents in patients with intestinal Behçet's disease by Miyazaki, Haruka, Watanabe, Daisuke, Okamoto, Norihiro, Tokunaga, Eri, Ku, Yuna, Takenaka, Haruka, Hoshi, Namiko, Ooi, Makoto, Kodama, Yuzo

    Published in BMC gastroenterology (28-03-2022)
    “…Behçet's disease (BD) is a recurrent multisystem inflammatory disease. Anti-tumor necrosis factor (TNF) α agents have been used to treat patients with…”
    Get full text
    Journal Article
  8. 8

    GPR43 Suppresses Intestinal Tumor Growth by Modification of the Mammalian Target of Rapamycin Complex 1 Activity in ApcMin/+ Mice by Kong, Lingling, Hoshi, Namiko, Sui, Yunlong, Yamada, Yasutaka, Yoshida, Ryutaro, Ooi, Makoto, Tian, Zibin, Kimura, Ikuo, Kodama, Yuzo

    Published in Medical principles and practice (2022)
    “…Objective: G protein-coupled receptor 43 (GPR43), a receptor for short-chain fatty acids, plays a role in suppressing tumor growth; however, the detailed…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    A novel gas chromatography mass spectrometry-based serum diagnostic and assessment approach to ulcerative colitis by Kohashi, Michitaka, Nishiumi, Shin, Ooi, Makoto, Yoshie, Tomoo, Matsubara, Atsuki, Suzuki, Makoto, Hoshi, Namiko, Kamikozuru, Koji, Yokoyama, Yoko, Fukunaga, Ken, Nakamura, Shiro, Azuma, Takeshi, Yoshida, Masaru

    Published in Journal of Crohn's and colitis (01-09-2014)
    “…To improve the clinical course of ulcerative colitis (UC), more accurate serum diagnostic and assessment methods are required. We used serum metabolomics to…”
    Get full text
    Journal Article
  13. 13

    A case of autoimmune enteropathy with CTLA4 haploinsufficiency by Miyazaki, Haruka, Hoshi, Namiko, Kohashi, Michitaka, Tokunaga, Eri, Ku, Yuna, Takenaka, Haruka, Ooi, Makoto, Yamamoto, Nobuyuki, Uemura, Suguru, Nishimura, Noriyuki, Iijima, Kazumoto, Jimbo, Keisuke, Okano, Tsubasa, Hoshino, Akihiro, Imai, Kohsuke, Kanegane, Hirokazu, Kobayashi, Ichiro, Kodama, Yuzo

    Published in Intestinal research (01-01-2022)
    “…Autoimmune enteropathy (AIE) is a rare disease, characterized by intractable diarrhea, villous atrophy of the small intestine, and the presence of circulating…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Side Effects of COVID-19 Vaccines in Patients with Inflammatory Bowel Disease in Japan by Miyazaki, Haruka, Watanabe, Daisuke, Ito, Yuki, Okamoto, Norihiro, Tokunaga, Eri, Ku, Yuna, Ooi, Makoto, Hoshi, Namiko, Kodama, Yuzo

    Published in Digestive diseases and sciences (01-02-2023)
    “…Background Patients with inflammatory bowel disease (IBD) are recommended to receive the coronavirus disease 2019 (COVID-19) vaccine. However, a recent survey…”
    Get full text
    Journal Article
  16. 16

    Differences in Coronavirus disease - 19 vaccination related side effects in patients with ulcerative colitis and Crohn’s disease in Japan by Miyazaki, Haruka, Watanabe, Daisuke, Ito, Yuki, Ikeda, Sayaka, Okamoto, Norihiro, Tokunaga, Eri, Ku, Yuna, Ooi, Makoto, Hoshi, Namiko, Kodama, Yuzo

    Published in Indian journal of gastroenterology (01-10-2023)
    “…Background/Purpose of this study It has been recommended that individuals with inflammatory bowel disease (IBD) be vaccinated against Coronavirus disease - 19…”
    Get full text
    Journal Article
  17. 17
  18. 18

    GCMS‐based metabolomic study in mice with colitis induced by dextran sulfate sodium by Shiomi, Yuuki, Nishiumi, Shin, Ooi, Makoto, Hatano, Naoya, Shinohara, Masakazu, Yoshie, Tomoo, Kondo, Yasuyuki, Furumatsu, Keisuke, Shiomi, Hideyuki, Kutsumi, Hiromu, Azuma, Takeshi, Yoshida, Masaru

    Published in Inflammatory bowel diseases (01-11-2011)
    “…Background: Metabolomics provides data about all the metabolic processes of a cell or organism. So far, the changes that occur in the levels of metabolites…”
    Get full text
    Journal Article
  19. 19

    Efficacy and predictor of anti-TNF[alpha] agents in patients with intestinal Behçet's disease by Miyazaki, Haruka, Watanabe, Daisuke, Okamoto, Norihiro, Tokunaga, Eri, Ku, Yuna, Takenaka, Haruka, Hoshi, Namiko, Ooi, Makoto, Kodama, Yuzo

    Published in BMC gastroenterology (28-03-2022)
    “…Background Behçet's disease (BD) is a recurrent multisystem inflammatory disease. Anti-tumor necrosis factor (TNF) [alpha] agents have been used to treat…”
    Get full text
    Journal Article
  20. 20